Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas: A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry

Cancer

Volumn 77, Issue 3, 1996, Pages 514-521

  Jochum, Wolfram ^a   Schröder, Sören ^b,g   Al Taha, Ramin ^c   August, Christian ^d   Gross, Andreas J ^e   Berger, Jürgen ^f   Padberg, Barbara Christina ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Inst Immunol   (Germany)

^c Allgemeines Krankenhaus Eilbek   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f UNIVERSITY OF HAMBURG   (Germany)

^g Division of Molecular Pathology   (Germany)

Author keywords

DNA cytophotometry; Ki 67; MIB 1; prognosis; proliferative activity; renal cell carcinoma

Indexed keywords

CELL NUCLEUS DNA; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPHOTOMETRY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MITOSIS INDEX; NEPHRECTOMY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030032654     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19960201)77:3<514::aid-cncr13>3.3.co;2-2     Document Type: Article

References (66)

1. Hall PA, Levison DA. Assessment of cell proliferation in histological material (Review). J Clin Pathol 1990;43:184-92.
2. Linden MD, Torres FX, Kubus J, Zarbo RJ. Clinical application of morphologic and immunocytochemical assessments of cell proliferation. Am J Clin Pathol 1992;97:S4-S13.
3. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969;101:297-301.
4. Hermanek P, Sobin LH, editors. UICC TNM classification of malignant tumours. 4th edition. 2nd revision. Berlin: Springer-Verlag, 1992.
5. Thoenes W, Störkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 1986;181:125-43.
6. van Diest PJ, Baak JPA, Matze-Cok P, Wisse-Brekelmans ECM, van Galen CM, Kurver PHJ, et al. Reproducibility of mitosis counting in 2,469 breast cancer specimens: Results from the multicenter morphometric mammary carcinoma project. Hum Pathol 1992;23:603-7.
7. Padberg BC, Garbe E, Achilles E, Dralle H, Bressel M, Schröder S. Adrenomedullary hyperplasia and phaeochromocytoma: DNA cytophotometric findings in 47 cases. Virchows Archiv A Pathol Anat Histopathol 1990;416:443-6.
8. Auer G, Caspersson TO, Wallgren AS. DNA content and survival in mammary carcinoma. Anal Quant Cytol Histol 1980;2:161-5.
9. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
10. Simpson JF, Dutt PL, Page DL. Expression of mitoses per thousand cells and cell density in breast carcinomas: a proposal. Hum Pathol 1992;23:608-11.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
12. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
13. Delahunt B, Nacey JN. Renal cell carcinoma II. Histological indicators of prognosis. Pathology 1987;19:258-63.
14. Störkel S, Thoenes W, Jacobi GH, Lippold R. Prognostic parameters in renal cell carcinomas - a new approach. Eur Urol 1989;16:416-22.
15. Strohmeyer T, Ackermann R. Classic and modern prognostic indicators of renal cell carcinoma. Urol Int 1991;47:203-12.
16. Gelb AB, Shibuya RB, Weis LM, Medeiros LJ. Stage I renal cell carcinoma. A clinicopathologic study of 82 cases. Am J Surg Pathol 1993;17:275-86.
17. Targonski PV, Frank W, Stuhldreher D, Guinan PD. Value of tumor size in predicting survival from renal cell carcinoma among tumors, nodes and metastases stage 1 and stage 2 patients. J Urol 1994;152:1389-92.
18. Tosi P, Luzi P, Baak JPA, Miracco C, Santopietro R, Vindigni C, et al. Nuclear morphometry as an important prognostic factor in stage I renal cell carcinoma. Cancer 1986;58:2512-8.
19. Murphy GF, Partin AW, Maygarden SJ, Mohler JL. Nuclear shape analysis for assessment of prognosis in renal cell carcinoma. J Utol 1990;143:1103-7.
20. Pound CR, Partin AW, Epstein JJ, Simons JW, Marshall FF. Nuclear morphometry accurately predicts recurrence in clinically localized renal cell carcinoma. Urology 1993; 42:243-8.
21. Artacho-Perula E, Roldan-Villalobos R, Martinez-Cuevas JT. Value of volume weighted mean nuclear volume in grading and prognosis of renal cell carcinoma. J Clin Pathol 1994;47:324-8.
22. Bot FJ, Godschalk JCJ, Krishnadath KK, van der Kwast THM, Bosman FT. Prognostic factors in renal-cell carcinoma: immunohistochemical detection of p53 protein versus clinicopathological parameters. Int J Cancer 1994;57:634-7.
23. Uhlman DL, Nguyen PL, Manivel JC, Aeppli D, Resnick JM, Fraley EE, et al. Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma. J Natl Cancer Inst 1994;86:1470-5.
24. Baisch H, Otto U, König K, Klöppel G, Köllermann M, Linden WA. DNA content of human kidney carcinoma cells in relation to histological grading. Br J Cancer 1982;45:878-86.
25. Klöppel G, Knöfel WT, Baisch H, Otto U. Prognosis of renal cell carcinoma related to nuclear grade, DNA content and Robson stage. Eur Urol 1986;12:426-31.
26. Grignon DJ, Ayala AG, El-Naggar A, Wishnow KI, Ro JY, Swanson DA, et al. Renal cell carcinoma. A clinicopathologic and DNA flow cytometric analysis of 103 cases. Cancer 1989;64:2133-40.
27. Bennington JL, Mayall BH. DNA cytometry on four-micrometer sections of paraffin-embedded human renal cell adenocarcinomas and adenomas. Cytometry 1983;4:31-9.
28. Otto U, Baisch H, Huland H, Klöppel G. Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma. J Urol 1984;132:237-9.
29. Chin JL, Pontes JE, Frankfurt OS. Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma. J Urol 1985;133:582-5.
30. Ljungberg B, Forsslund G, Stenling R, Zetterberg A. Prognostic significance of the DNA content in renal cell carcinoma. J Urol 1986;135:422-6.
31. Baisch H, Otto U, Klöppel G. Malignancy index based on flow cytometry and histology for renal cell carcinomas and its correlation to prognosis. Cytometry 1986;7:200-4.
32. Rainwater LM, Hosaka Y, Farrow GM, Lieber MM. Well differentiated clear cell renal carcinoma: significance of nuclear deoxyribonucleic acid patterns studied by flow cytometry. J Urol 1987;137:15-20.
33. Ekfors TO, Lipasti J, Nurmi MJ, Eerola E. Flow cytometric analysis of the DNA profile of renal cell carcinoma. Pathol Res Pract 1987;182:58-2.
34. Oosterwijk E, Warnaar SO, Zwartendijk J, van der Velde EA, Fleuren GJ, Cornelisse CJ. Relationship between DNA ploidy, antigen expression and survival in renal cell carcinoma. Int J Cancer 1988;42:703-8.
35. DeKernion JB, Mukamel E, Ritchie AWS, Blyth B, Hannah J, Bohman R. Prognostic significance of the DNA content of renal carcinoma. Cancer 1989;64:1669-73.
36. Grignon DI, El-Naggar A, Green LK, Ayala AG, Ro JY, Swanson DA, et al. DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma. Cancer 1989;63:1161-5.
37. Currin SM, Lee SE, Walther PJ. Flow cytometric assessment of DNA content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone? J Urol 1990;143:458-63.
38. Yu DS, Hsu CM, Lee WH, Chang SY, Ma CP. Flow cytometric DNA and cytophotometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis. J Surg Res 1993;55:480-5.
39. Lanigan DJ, McLean PA, Murphy DM, Donovan MG, Leader M. Image analysis in the determination of ploidy and prognosis in renal cell carcinoma. Eur Urol 1992;22:228-34.
40. Nakano E, Kondoh M, Okatani K, Seguchi T, Sugao H. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features. Cancer 1993;72:1319-23.
41. Steinbach F, Stöckle M, Kiewel R, Störkel S, Stein R, Hohenfellner R. Prognostic parameters in renal cell carcinoma. Clinicopathologic and DNA image cytometric analysis in 133 pT3a cases. Eur Urol 1993;24:279-85.
42. Grignon DJ, Abdel-Malak M, Mertens W, Koster J, Keeney M, Sakr W, et al. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index. Mod Pathol 1995;8:18-24.
43. Flint A, Grossman HB, Liebert M, Lloyd RV, Bromberg J. DNA and PCNA content of renal cell carcinoma and prognosis. Am J Clin Pathol 1995;103:14-9.
44. Larsson P, Roos G, Stenling R, Ljungberg B. Tumor-cell proliferation and prognosis in renal-cell carcinoma. Int J Cancer 1993;55:566-70.
45. Ljungberg B, Stenling R, Roos G. DNA content in renal cell carcinoma with reference to tumor heterogeneity. Cancer 1985;56:503-8.
46. Claud RD, Weinstein RS, Howeedy A, Straus AK, Coon JS. Comparison of image analysis of imprints with flow cytometry for DNA analysis of solid tumors. Mod Pathol 1989;2:463-7.
47. Steinbeck R, Askensten U, Auer G. Die Wertigkeit der DNA-Analyse in soliden Tumoren. Eine Übersicht für den klinisch tätigen Pathologen. Pathologe 1989;10:171-6.
48. Lanigan D, McLean PA, Curran B, Leader M. Comparison of flow and static image cytometry in the determination of ploidy. J Clin Pathol 1993;46:135-9.
49. Delahunt B, Ribas JL, Nacey JN, Bethwaite PB. Nucleolar organizer regions and prognosis in renal cell carcinoma. J Pathol 1991;163:31-7.
50. Pich A, Valante G, Azzoni L, Stramignoni A, Margaria E, Tasso M. Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma. Pathol Res Pract 1991;187:482-6.
51. Celis JE, Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 1985;82:3262-6.
52. Delahunt B, Bethwaite PB, Nacey JN, Ribas JL. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers. J Pathol 1993;170:471-7.
53. Cronin KJ, Williams NN, Kerin MJ, Creagh TA, Dervan PA, Smith JM, et al. Proliferating cell nuclear antigen: a new prognostic indicator in renal cell carcinoma. J Urol 1994;152:834-6.
54. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
55. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-5.
56. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73.
57. Key G, Becker MHG, Baron B, Duchrow M, Schlüter C, Flad HD, et al. New Ki-67-equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993;68:629-36.
58. Gerdes J, Becker MHG, Key G, Cattoretti G. Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992;168:85-7.
59. Schlüter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Flad HD, et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993;123:513-22.
60. Kubbutat MHG, Key G, Duchrow M, Schlüter C, Flad HD, Gerdes J. Epitope analysis of antibodies recognising the cell proliferation associated nuclear antigen previously defined by the antibody Ki-67 (Ki-67 protein). J Clin Pathol 1994;47:524-8.
61. de Riese WTW, Crabtree WN, Alhoff EP, Werner M, Liedke S, Lenis G, et al. Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma. J Clin Oncol 1993;11:1804-8.
62. Papadopoulos I, Weichert-Jacobsen K, Sprenger E, Wacker HH. DNA content and the proliferation marker Ki-67 as prognostic indicators in renal cell carcinoma. Urol Int 1994;53:181-5.
63. Delahunt B, Bethwaite PB, Thornton A, Ribas JL. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome. Cancer 1995;75:2714-9.
64. Barbareschi M, Girlando S, Mauri FM, Forti S, Eccher C, Mauri FA, et al. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol 1994;102:171-5.
65. Mazerolles C, Rishmann P, Chopin D, Popov Z, Malavaud B, Selves I, et al. Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki-67 antibody. Histopathology 1994;25:563-8.
66. Weidner N, Moore DH, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel paraffin-reactive MIB1 antibody. Hum Pathol 1994;25:337-42.